Alpha Teknova, Inc. (TKNO) Form 10-K Annual Reports
Alpha Teknova, Inc. (TKNO) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TKNO
CIK: 1850902
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerDominic Mills
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338178 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001193125-26-335059 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | PRIMARY DOCUMENT | 0001198230-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | PRIMARY DOCUMENT | 0001866687-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | PRIMARY DOCUMENT | 0001211809-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-02 | 2026-06-01 | PRIMARY DOCUMENT | 0001198230-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-27 | 8-K | 0001850902-26-000011 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001850902-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-04 | 8-K | 0001850902-26-000007 | View SEC Doc Filr Page |
| ARS | 2026-04-21 | 2025-12-31 | ARS | 0001193125-26-167275 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-21 | — | DEFA14A | 0001193125-26-167271 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-21 | 2026-04-21 | DEF 14A | 0001193125-26-167248 | View SEC Doc Filr Page |
| 4 | 2026-03-09 | 2026-02-15 | PRIMARY DOCUMENT | 0001859826-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-03-09 | 2026-02-15 | PRIMARY DOCUMENT | 0001861091-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-03-09 | 2026-02-15 | PRIMARY DOCUMENT | 0001861134-26-000002 | View SEC Doc Filr Page |
| 10-K | 2026-03-02 | 2025-12-31 | 10-K | 0001850902-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | 8-K | 0001193125-26-076592 | View SEC Doc Filr Page |
| 10-Q | 2025-11-07 | 2025-09-30 | 10-Q | 0001193125-25-272321 | View SEC Doc Filr Page |
| 8-K | 2025-11-06 | 2025-11-06 | 8-K | 0001193125-25-269488 | View SEC Doc Filr Page |
| 10-Q | 2025-08-08 | 2025-06-30 | 10-Q | 0000950170-25-105825 | View SEC Doc Filr Page |
| 8-K | 2025-08-07 | 2025-08-07 | 8-K | 0000950170-25-105005 | View SEC Doc Filr Page |
| EFFECT | 2025-07-16 | — | EFFECT Filing | 9999999995-25-002267 | View SEC Doc Filr Page |
| CORRESP | 2025-07-14 | — | CORRESP Filing | 0001193125-25-158828 | View SEC Doc Filr Page |
| UPLOAD | 2025-07-14 | — | UPLOAD Filing | 0000000000-25-007383 | View SEC Doc Filr Page |
| S-3 | 2025-07-10 | — | S-3 | 0001193125-25-157628 | View SEC Doc Filr Page |